Evidence that human kidney produces a protein similar to lithostathine, the pancreatic inhibitor of CaCO3 crystal growth.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  European Journal of Clinical Investigation

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-1-4615-2556-1_107PMID 1516594
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preliminary treatment of urinary proteins improves electrophoretic analysis and immunodetection.

  1992cited by this paper
• Protein inhibitors of crystallization.

  1991cited by this paper
• Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation.

  1990cited by this paper
• Renaming pancreatic stone protein as 'lithostathine'.

  1990cited by this paper
• Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.

  1989cited by this paper
• Isolation of an acidic protein from cholesterol gallstones, which inhibits the precipitation of calcium carbonate in vitro.

  1989cited by this paper
• Secretory pancreatic stone protein messenger RNA. Nucleotide sequence and expression in chronic calcifying pancreatitis.

  1989cited by this paper
• Prevalence of calcified upper urinary tract stone disease in a random population survey. Report of a combined study of general practitioners and hospital staff.

  1987cited by this paper
• Glycosaminoglycans as inhibitors of stone formation.

  1987cited by this paper
• Complete amino acid sequence of an immunoreactive form of human pancreatic stone protein isolated from pancreatic juice.

  1987cited by this paper
• Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.

  1987cited by this paper
• Immunocytochemical Localization of Pancreatic Stone Protein in the Human Digestive Tract

  1986cited by this paper
• Partial amino acid sequence of human pancreatic stone protein, a novel pancreatic secretory protein.

  1986cited by this paper
• Pancreatic stone protein. II. Implication in stone formation during the course of chronic calcifying pancreatitis.

  1985cited by this paper
• The molecular characteristics of a human pancreatic acidic phosphoprotein that inhibits calcium carbonate crystal growth.

  1984cited by this paper
• Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine.

  1983cited by this paper
• Pancreatic stone protein, a phosphoprotein which inhibits calcium carbonate precipitation from human pancreatic juice.

  1983cited by this paper
• Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine.

  1983cited by this paper
• Phosphoproteins in the parotid saliva from the subhuman primate Macaca fascicularis. Isolation and characterization of a proline-rich phosphoglycoprotein and the complete covalent structure of a proline-rich phosphopeptide.

  1982cited by this paper
• Prevalence and incidence of renal stone disease in a german population sample

  1981cited by this paper
• "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

  1981cited by this paper
• Characterization of a protein isolated from pancreatic calculi of men suffering from chronic calcifying pancreatitis.

  1979cited by this paper
• The transition of the thick ascending limb of Henle's loop into the distal convoluted tubule in the nephron of the rat kidney

  1977cited by this paper
• Contraluminal serum albumin uptake in isolated perfused renal tubules.

  1973cited by this paper
• The effect of luminal application of colloids on rat proximal tubular net fluid flux.

  1972cited by this paper
• Aspects of tubular reabsorption revisited.

  1970cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Isolation from urine of pyrophosphate, a calcification inhibitor.

  1962cited by this paper

• Association between elevated serum REG Iα levels and eGFR decline in patients with chronic kidney disease: a cross-sectional study in eastern China

  2025cites this paper
• Pancreatic Stone Protein as a Versatile Biomarker: Current Evidence and Clinical Applications

  2025cites this paper
• Association of Serum PSP/REG Iα with Renal Function in Type 2 Diabetes Mellitus

  2020cites this paper
• Proteomic analysis of AQP11-null kidney: Proximal tubular type polycystic kidney disease

  2017cites this paper
• [Crystalluria].

  2015cites this paper
• Lithostatine Concentration Is not Useful for Assessing the Preanalytical Variations in Biobanked Urine Samples

  2013cites this paper
• Nephrolithiasis: Molecular Mechanism of Renal Stone Formation and the Critical Role Played by Modulators

  2013cites this paper
• Pancreatic stone protein/regenerating protein family in pancreatic and gastrointestinal diseases.

  2011cites this paper
• Peripheral Blood Based Discrimination of Ulcerative Colitis and Crohn’s Disease from Non-IBD Colitis by Genome-Wide Gene Expression Profiling

  2011cites this paper
• The Role of Urinary Kidney Stone Inhibitors and Promoters in the Pathogenesis of Calcium Containing Renal Stones

  2007cites this paper
• Expression Profiling of Crystal-Induced Injury in Human Kidney Epithelial Cells

  2006cites this paper
• Polarized calcium and calmodulin signaling in secretory epithelia.

  2002cites this paper
• Urinary Kidney Stone Inhibitors. What Is the New?

  1998cites this paper
• Urinary excretion of pancreatic stone protein in diabetic nephropathy.

  1998cites this paper
• Mechanism of stone formation.

  1997cites this paper
• Inhibitors of stone formation.

  1996cites this paper
• Calcium Carbonate Crystals Promote Calcium Oxalate Crystallization by Heterogeneous or Epitaxial Nucleation: Possible Involvement in the Control of Urinary Lithogenesis

  1996cites this paper
• [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].

  1996cites this paper
• Nh2‐Terminal sequence of novel pancreatic stone protein‐related protein in human urine

  1995cites this paper
• Analysis of the soluble organic matrix of five morphologically different kidney stones

  1995cites this paper
• Immunological characterization of pancreatic stone protein in human urine

  1994cites this paper
• Enzyme immunoassay and characterization of pancreatic stone proteins in human urine

  1993cites this paper